KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Travere Therapeutics (TVTX) Change in Acquisitions & Divestments (2016 - 2025)

Travere Therapeutics (TVTX) has disclosed Change in Acquisitions & Divestments for 13 consecutive years, with $82.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Acquisitions & Divestments rose 49.72% year-over-year to $82.4 million, compared with a TTM value of $323.6 million through Dec 2025, down 0.84%, and an annual FY2025 reading of $323.6 million, down 0.84% over the prior year.
  • Change in Acquisitions & Divestments was $82.4 million for Q4 2025 at Travere Therapeutics, down from $106.6 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $152.6 million in Q2 2022 and bottomed at $50.0 million in Q4 2023.
  • Average Change in Acquisitions & Divestments over 5 years is $90.0 million, with a median of $88.7 million recorded in 2021.
  • The sharpest move saw Change in Acquisitions & Divestments soared 210.05% in 2021, then tumbled 57.54% in 2022.
  • Year by year, Change in Acquisitions & Divestments stood at $57.5 million in 2021, then fell by 8.91% to $52.4 million in 2022, then fell by 4.55% to $50.0 million in 2023, then grew by 10.1% to $55.0 million in 2024, then skyrocketed by 49.72% to $82.4 million in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for TVTX at $82.4 million in Q4 2025, $106.6 million in Q3 2025, and $81.4 million in Q2 2025.